Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Buy
+162,616
New +$2.9M 0.02% 66
2024
Q4
Sell
-148,706
Closed -$2.67M 70
2024
Q3
$2.67M Sell
148,706
-14,013,301
-99% -$255M 0.02% 64
2024
Q2
$249M Buy
14,162,007
+1,710,145
+14% +$35.3M 1.37% 24
2024
Q1
$319M Sell
12,451,862
-663,259
-5% -$16.6M 1.97% 21
2023
Q4
$339M Buy
13,115,121
+732,614
+6% +$16.7M 1.9% 17
2023
Q3
$285M Sell
12,382,507
-1,161,884
-9% -$29.1M 1.88% 19
2023
Q2
$318M Sell
13,544,391
-1,020,275
-7% -$17.3M 1.86% 19
2023
Q1
$173M Buy
14,564,666
+189,571
+1% +$2.7M 0.98% 41
2022
Q4
$221M Sell
14,375,095
-1,627,206
-10% -$28.5M 1.27% 28
2022
Q3
$304M Sell
16,002,301
-279,241
-2% -$5.54M 1.99% 18
2022
Q2
$293M Sell
16,281,542
-356,941
-2% -$8.22M 1.8% 18
2022
Q1
$351M Buy
16,638,483
+1,229,321
+8% +$38.3M 1.93% 17
2021
Q4
$443M Buy
+15,409,162
New +$502M 1.7% 21

Other funds holding XP

Harding Loevner's XP Position: Q2 2026 in Review

Harding Loevner opened a new position in XP (XP) in Q2 2026: 162,616 shares worth $2.64M. The stake represents 0.02% of the portfolio and ranks #66 among its holdings. This is a return to the name: Harding Loevner previously reported a position in XP as recently as Q3 2024.

Harding Loevner first reported a position in XP in Q4 2021 and has held it in 13 quarters since. The position peaked at $443M in Q4 2021. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Harding Loevner held 162,616 shares of XP worth $2.64M as of Q2 2026.
  • XP was a new Harding Loevner position in Q2 2026.
  • XP made up 0.02% of Harding Loevner's portfolio in Q2 2026, its #66 holding.
  • Harding Loevner first reported a position in XP in Q4 2021 and has held it in 13 quarters since.
  • Harding Loevner's XP position peaked at $443M in Q4 2021.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Harding Loevner's 13F filing for Q2 2026, filed 14 Aug 2026.